Patton Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,720
Closed -$347K 140
2026
Q1
$347K Buy
+5,720
New +$333K 0.06% 112
2025
Q4
Sell
-4,598
Closed -$207K 475
2025
Q3
$207K Hold
4,598
0.04% 430
2025
Q2
$213K Buy
+4,598
New +$226K 0.05% 431

Other funds holding BMY

Patton Fund Management's BMY Position: Q2 2026 in Review

Patton Fund Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 5,720 shares — an estimated $347K sold.

Patton Fund Management first reported a position in BMY in Q2 2025 and held it in 3 quarters. The position peaked at $347K in Q1 2026. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Patton Fund Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 5,720 Bristol-Myers Squibb shares in Q2 2026, an estimated $347K.
  • Patton Fund Management first reported a position in Bristol-Myers Squibb in Q2 2025 and held it in 3 quarters.
  • Patton Fund Management's Bristol-Myers Squibb position peaked at $347K in Q1 2026.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.